UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Sanofi to test new diabetic drug in phase-3 study
Sanofi-Aventis Korea said it would start phase-3 clinical trials (SAR439954...
by Lee Hye-seon
|
2018-04-26 14:40
라인
‘Switching Tylenol ER to prescription drug unnecessary’
Local pharmaceutical experts said the health authorities did not have to sw...
by Lee Hye-seon
|
2018-04-25 16:06
라인
Patent requests for brain-controlled wheelchairs surge
Patent applications for smart wheelchairs using brain-machine interface (BM...
by Lee Hye-seon
|
2018-04-20 15:46
라인
Seoul to simplify orphan drug designation
The Ministry of Food and Drug Safety (MFDS) on Wednesday said it would amen...
by Lee Hye-seon
|
2018-04-19 16:00
라인
Exhibition showcases latest pharma products, trends
An international pharmaceutical exhibition opened at the Korea Internationa...
by Lee Hye-seon
|
2018-04-17 16:14
라인
Dental implants drove up output growth of medical devices in 2017
Korea’s output of medical devices expanded 3.9 percent year-on-year to mark...
by Lee Hye-seon
|
2018-04-17 11:48
라인
Janssen Korea launches new psoriasis treatment
Janssen Korea said it has launched a follow-up drug of psoriasis treatment ...
by Lee Hye-seon
|
2018-04-16 11:48
라인
Hanmi gives up on lung cancer drug Olita
Hanmi Pharmaceutical is expected to discontinue developing lung cancer trea...
by Lee Hye-seon
|
2018-04-13 11:00
라인
LG Chem works on 3-in-1 combo for hypertension
LG Chem said it has won approval from the Ministry of Food and Drug Safety ...
by Lee Hye-seon
|
2018-04-12 16:32
라인
Il-yang’s ‘Supect’ loses 2nd indication for leukemia
The government said Tuesday Il-yang Pharmaceutical’s Supect (ingredient: ra...
by Lee Hye-seon
|
2018-04-10 15:14
라인
Filler study plans won the most approvals in 2017
Medical device manufacturers’ plans for clinical trials on filler developme...
by Lee Hye-seon
|
2018-04-04 14:55
라인
Seoul orders Janssen to fill up PMS cases to 3,000
Janssen Korea will have to increase the number of post-marketing surveillan...
by Lee Hye-seon
|
2018-04-02 16:30
라인
Heavy ion cancer therapy to arrive in Korea in 2022
Korean cancer patients will be able to receive a state-of-the-art heavy ion...
by Lee Hye-seon
|
2018-03-30 15:17
라인
Hanmi wins nod to test antihypertensive cocktail of 4 drugs
Hanmi Pharmaceutical has obtained approval to test a combination therapy of...
by Lee Hye-seon
|
2018-03-28 17:19
라인
Seoul OKs plan to test systemic sclerosis drug Lenabasum
The pharmaceutical industry is paying attention to whether Lenabasum, an in...
by Lee Hye-seon
|
2018-03-27 11:36
라인
Local drugmakers poor at winning nod for clinical trials
Samsung Medical Center obtained the most approvals for clinical trials in t...
by Lee Hye-seon
|
2018-03-23 12:04
라인
Jointstem fails to win conditional nod
Jointstem, a stem cell therapy for degenerative arthritis, failed to obtain...
by Lee Hye-seon
|
2018-03-19 12:12
라인
Locally developed surgical robot unveiled
Revo-i, the first locally developed laparoscopic surgical robot, is about t...
by Lee Hye-seon
|
2018-03-15 15:24
라인
Hepatitis B recurrence warning on anticancer drugs by Jeil, Myungmoon
The government said it would order Jeil Pharmaceutical and Myungmoon Pharm ...
by Lee Hye-seon
|
2018-03-13 11:47
라인
Clzapine warnings to add obesity, fall
The government has ordered Dongwha Pharm, regarding its Clzapine Tab. (ingr...
by Lee Hye-seon
|
2018-03-09 14:24
-
이전
11
12
13
14
15
16
17
18
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top